KURA ONCOLOGY

Company

Kura Oncology, Inc.

Filed

March 13, 2015

Accession Number

0001072613-15-000217

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →